# US 2021/0332040 A1 · SUBSTITUTED 4-AMINO-1H-IMIDAZO[4,5-c]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332040 A1
- Document ID: US20210332040A1
- Status: Published application
- Kind: A1
- Application number: 17/268,725
- Filed: 2019-08-15
- Published: 2021-10-28
- Earliest claimed: 2018-08-16
- Assignees: Innate Tumor Immunity, Inc.
- Applicants: Innate Tumor Immunity, Inc
- Inventors: Sha Lou; Adrian Ortiz; Rebecca A. Green; Christopher Robert Jamison; Candice Lee Joe; Sergei Kolotuchin; Eric M. Simmons; Neil A. Strotman; Matthew W. Haley; Yichen Tan; Andrew William Glace; Dong Lin; Albert J. DelMonte; Peng Geng; Bahar Inankur; Victor W. Rosso; Mansi S. Shah
- Web page: https://patentgrep.com/patent/US20210332040A1

## CPC

- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D 471/04: Ortho-condensed systems
- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C07D 233/66: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 233/68: Halogen atoms
- C07D 233/90: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Improved methods and intermediates thereof for preparing substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds are described. These compounds are useful as NLRP3 modulators.

## Claims

### Claim 1

A method of making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R1 is independently H, C1-6 alkyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), —S(O)1-2NRcRd, or —C(O)NRcRd;
R2 is independently H or C1-6 alkyl;
R3 is independently:
(vi) H;
(ii) C1-6 haloalkyl;
(iii) C1-8 alkyl optionally substituted with R6, wherein R6 is —OH, C1-4 alkoxy, —(CH2)1-4O(CH)(CH2)1-4(C1-4 alkoxy), C1-4 haloalkoxy, CO2Ra, or —CONRcRd; or
(vi) (C0-3 alkylene)-R7, wherein R7 is C3-6 cycloalkyl, phenyl, 5- to 6-membered heterocycloalkyl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, or 5- to 6-membered heteroaryl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S; and R7 is optionally substituted with halogen, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R4 is independently H, halogen, cyano, OH, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)OH, —C(O)ORa, —NRcRd, —C(O)NRcRd, —S(O)1-2(Rb), or C1-4 alkyl substituted with from 0 to 2 Rh;
R5 is independently halo or —(C0-3 alkylene)-(5-membered heteroaryl) wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re), O, and S, and is substituted with from 0 to 3 Rg;
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rb;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy; and
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2 and R4 are as defined as above for Formula (I);
R3a is independently R3, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
R8 is independently halo or —(C0-3 alkylene)-(5-membered heteroaryl) wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R11 is independently NH2 or NO2;
R12 is independently H, C1-6 alkyl, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), —S(O)1-2NRcRd, —C(O)NRcRd, or
Re1 is independently H, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
and
Rg1 is independently H, halo, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
with a mixture of Reagent 1 selected from a Brønsted acid, a Lewis acid, and a transition metal catalyst or a combination thereof, with or without Base 1 selected from a Brønsted base and a Lewis base, with or without an additive, in Solvent 1 that is a protic, aprotic or polar organic solvent or organic solvent mixture;
for a time and at a temperature sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, and R4 are as defined as above for Formula (I), and R8, and R12 are as defined as above for Formula (II);
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from a Brønsted acid, a Lewis acid, a Brønsted base, and a Lewis base, in Solvent 2 that is a protic, aprotic or polar solvent or solvent mixture, for a time and at a temperature sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 2 (depends on 1)

The method according to claim 1 for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R5 is independently 5-membered heteroaryl wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re), O, and S, and is substituted with from 0 to 3 Rg;
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) CF3;
(iii) C3-6 cycloalkyl optionally substituted with from 1 to 2 Rf;
(vi) heterocyclyl including from 5 to 7 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein: R2 and R4 are as defined as above for Formula (I);
R3a is independently R3, C(O)Ra, —C(O)ORa,
R8 is independently 5-membered heteroaryl wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
and
Re1 is independently H, C(O)Ra, —C(O)ORa,
with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from −20° C. to 120° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, and R4 are as defined as above for Formula (I), and R8, and R12 are as defined as above for Formula (II);
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA, EtOH or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from −20° C. to 120° C. sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 3 (depends on 2)

The method according to claim 2, for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R1 is independently C1-6 alkyl, C(O)Ra, —C(O)ORa, —S(O)2(Rb), or —C(O)NRcRd;
R2 is independently H or C1-3 alkyl;
R3 is independently H, C1-4 haloalkyl, C1-6 alkyl optionally substituted with R6, wherein R6 is CO2Ra or —CONRcRd;
R4 is independently H, halogen, C1-4 alkyl or C1-4 alkoxy;
R5 is independently 5-membered heteroaryl wherein the heteroaryl includes 2 to 4 ring carbon atoms and 1 to 3 ring heteroatoms are each independently selected from: N, N(Re), O, and S, and is substituted with from 0 to 3 Rg;
Ra is independently CF3, C1-4 alkyl optionally substituted with OH, C3-6 cycloalkyl, phenyl, or heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S; and
Rb is C1-4 alkyl;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein:
R3a is independently R3, C(O)Ra, —C(O)ORa,
R8 is independently 5-membered heteroaryl wherein the heteroaryl includes 2 to 4 ring carbon atoms and 1 to 3 ring heteroatoms each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R12 is independently H, C(O)Ra, —C(O)ORa, or
Re1 is independently H, C(O)Ra, —C(O)ORa,
and
Rg1 is independently H, halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from 20° C. and 90° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof:
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA, EtOH or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 20° C. to 80° C. sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 4 (depends on 3)

The method according to claim 3 for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II) as defined in the 3rd aspect, or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from 20° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof;
and (2) contacting the compound of Formula (III) as defined in the 3rd aspect, or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 20° C. to 80° C. sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 5 (depends on 3)

The method according to claim 3, for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R1 is independently C1-6 alkyl, C(O)Ra, —C(O)ORa, —S(O)2(CH3), or —C(O)N(CH3)2;
R2 is independently H, CH3 or CH2CH3,
R3 is independently H, CH3, or —(CH2)3C(═O)OCH3;
R4 is independently H, F, Cl, C1-2 alkyl or C1-2 alkoxy;
R5 is independently pyrazolyl, thiazolyl or thienyl; and
Ra is independently C1-4 alkyl, cyclopropyl, or thiazolyl;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein:
R3a is independently R3,
R8 is independently N—(Re1)-pyrazolyl, N—(Re1)-thiazolyl or thienyl;
R12 is independently H, C(O)Ra, —C(O)ORa, or
and
Re1 is independently H, C(O)Ra, —C(O)ORa,
with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from 30° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof:
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA, EtOH or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 40° C. to 80° C. sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 6 (depends on 5)

The method according to claim 5 for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II) as defined in the 5th aspect, or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 8 to 48 hours and at a temperature ranging from 40° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof;
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 40° C. to 80° C. sufficient for hydrolysis and/or de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 7 (depends on 3)

The method according to claim 3, for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R1 is independently C1-6 alkyl or C(O)C1-4 alkyl;
R2 is independently H, CH3 or CH2CH3,
R3 is independently H, CH3, or —(CH2)3C(═O)OCH3;
R4 is independently H, F, Cl, C1-2 alkyl or C1-2 alkoxy; and
R5 is pyrazolyl;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein:
R3a is independently R3,
R8 is N—(Re1)-pyrazolyl;
R12 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl, or
and
Re1 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl
and
Rg1 is independently H, halo or C1-4 alkyl;
with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from 30° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof:
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA, EtOH or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 40° C. to 80° C. sufficient for hydrolysis and de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 8 (depends on 7)

The method according to claim 7 for making a compound of Formula (I), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 8 to 48 hours and at a temperature ranging from 40° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof;
and (2) contacting the compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof, with Reagent 2 selected from HCl, HBr, H2SO4, H3PO4, HBF4, 1,5-naphthalenedisulfonic acid, benzenesulfonic acid, methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and ethanesulfonic acid or a combination thereof, in Solvent 2 selected from MTBE, MeOH, MIBK, iPrOAc, toluene, 2-Me-THF, MeCN, CPME, IPA or a combination thereof, with or without water, for a time from 1 to 48 hours and at a temperature ranging from 40° C. to 80° C. sufficient for hydrolysis and de-protection and to produce the compound of Formula (I), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 9

A compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R8 is independently N—(Re1)-pyrazolyl, N—(Re1)-thiazolyl;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
Re1 is independently C(O)C1-4 alkyl, —C(O)OC1-4 alkyl,
and
Rg1 is independently H, halo or C1-4 alkyl.

### Claim 10 (depends on 9)

The compound according to claim 9, wherein:
R2 is independently H or C1-3 alkyl;
R3 is independently H, C1-4 haloalkyl, C1-6 alkyl optionally substituted with R6, wherein R6 is CO2Ra or —CONRcRd;
R4 is independently H, halogen, C1-4 alkyl or C1-4 alkoxy;
R8 is N—(Re1)-pyrazolyl;
R12 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl, or
and
Re1 is independently Bn, Boc, or

### Claim 11

A compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R3a is independently R3, C(O)Ra, —C(O)ORa,
R8 is independently 5-membered heteroaryl wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
Re1 is independently H, C(O)Ra, —C(O)ORa,
and
Rg1 is independently H, halo, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy.

### Claim 12 (depends on 11)

The compound according to claim 11, wherein:
R8 is independently N—(Re1)-pyrazolyl, N—(Re1)-thiazolyl; and
Re1 is independently H, C(O)C1-4 alkyl, —C(O)O C1-4 alkyl,
and
Rg1 is independently H, halo or C1-4 alkyl.

### Claim 13 (depends on 12)

The compound according to claim 12, wherein:
R8 is N—(Re1)-pyrazolyl; and
Re1 is independently H, Bn, Boc, or

### Claim 14

A method of making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently:
(vi) H;
(ii) C1-6 haloalkyl;
(iii) C1-8 alkyl optionally substituted with R6, wherein R6 is —OH, C1-4 alkoxy, —(CH2)1-4O(CH)(CH2)1-4(C1-4 alkoxy), C1-4 haloalkoxy, CO2Ra, or —CONRcRd; or
(vi) (C0-3 alkylene)-R7, wherein R7 is C3-6 cycloalkyl, phenyl, 5- to 6-membered heterocycloalkyl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, or 5- to 6-membered heteroaryl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S; and R7 is optionally substituted with halogen, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R4 is independently H, halogen, cyano, OH, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)OH, —C(O)ORa, —NRcRd, —C(O)NRcRd, —S(O)1-2(Rb), or C1-4 alkyl substituted with from 0 to 2 Rh;
R8 is independently halo or —(C0-3 alkylene)-(5-membered heteroaryl) wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R12 is independently H, C1-6 alkyl, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), —S(O)1-2NRcRd, —C(O)NRcRd, or
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy; and
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
Re1 is independently H, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
and
Rg1 is independently H, halo, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, R4, R8 and R12 are as defined as above for Formula (I);
R3a is independently R3, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
R11 is independently NH2 or NO2;
with a mixture of Reagent 1 selected from a Brønsted acid, a Lewis acid, and a transition metal catalyst or a combination thereof, with or without Base 1 selected from a Brønsted base and a Lewis base, with or without an additive, in Solvent 1 that is a protic, aprotic or polar organic solvent or organic solvent mixture;
for a time and at a temperature sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 15 (depends on 14)

The method according to claim 14 for making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) CF3;
(iii) C3-6 cycloalkyl optionally substituted with from 1 to 2 Rf;
(vi) heterocyclyl including from 5 to 7 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from −20° C. to 120° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 16 (depends on 14)

The method according to claim 14 for making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) CF3;
(iii) C3-6 cycloalkyl optionally substituted with from 1 to 2 Rf;
(vi) heterocyclyl including from 5 to 7 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof:
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from −20° C. to 120° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 17 (depends on 15)

The method according to claim 15 for making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from 20° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 18 (depends on 17)

The method according to claim 17 for making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from 20° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 19 (depends on 17)

The method according to claim 17 for making a compound of Formula (III), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof, with a mixture of Reagent 1 selected from dichloroacetic acid, acetic acid, p-toluenesulfonic acid, HCl, citric acid, diphenylphosphinic acid, oxalic acid, methyl phosphonic acid, phenylphosphonic acid, salicylic acid and hydrido(dimethylphosphinous acid-kP)[hydrogen bis(dimethylphosphinito-kP)]platinum (II) or a combination thereof, with or without Base 1 selected from NaOAc, KOAc, NaOPiv, KOPiv, NaOMe, KOMe and N,N-diisopropylethylamine, with or without an additive selected from pyrrole, N-methylpyrrole, (carboxymethyl)trimethylammonium chloride hydrazide, 2,4-dimethylpyrrole, 2,5-dimethylpyrrole, 4-methoxy-2-methylindole, 2-methylfuran, 1,2-dimethylindole, 2-methylthiophene, and N-methylindole, in Solvent 1 selected from MeOH, MeTHF, BuOH, EtOH, THF, DMF, NMP, DMF, dioxane, toluene, DME, and DMAc or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from 30° C. and 80° C. sufficient for cyclization and to produce a compound of Formula (III), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 20

A method of making a compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
R2 is independently H or C1-6 alkyl;
R3 is independently:
(i) H;
(ii) C1-6 haloalkyl;
(iii) C1-8 alkyl optionally substituted with R6, wherein R6 is —OH, C1-4 alkoxy, —(CH2)1-4O(CH)(CH2)1-4(C1-4 alkoxy), C1-4 haloalkoxy, CO2Ra, or —CONRcRd; or
(vi) (C0-3 alkylene)-R7, wherein R7 is C3-6 cycloalkyl, phenyl, 5- to 6-membered heterocycloalkyl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, or 5- to 6-membered heteroaryl containing from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S; and R7 is optionally substituted with halogen, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R3a is independently R3, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
R4 is independently H, halogen, cyano, OH, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, —C(O)OH, —C(O)ORa, —NRcRd, —C(O)NRcRd, —S(O)1-2(Rb), or C1-4 alkyl substituted with from 0 to 2 Rh;
R8 is independently halo or —(C0-3 alkylene)-(5-membered heteroaryl) wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from:
N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R11 is independently NH2 or NO2;
R12 is independently H, C1-6 alkyl, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), —S(O)1-2NRcRd, —C(O)NRcRd, or
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy; and
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
Re1 is independently H, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb),
and
Rg1 is independently H, halo, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
comprising (1) contacting a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof:
wherein R4, R8, and R11 are as defined as above for Formula (II);
R13 is independently H, halogen, —OS(O)2Rb1, —B(ORb2)2, or —BF3K;
Rb1 is independently C1-4 alkyl, C1-4 haloalkyl, or phenyl substituted with from 0 to 3 Rg2;
Rb2 is independently H or C1-4 alkyl;
alternatively, two Rb2s together with the oxygen atoms to which they are attached, forms heterocyclyl including the boron atom and additional 2 to 5 ring carbon atoms, wherein the heterocyclyl is substituted with from 0 to 4 Rb2;
Rb2 is independently C1-4 alkyl or —C(O)OC1-4 alkyl;
alternatively, two Rb2s together with the oxygen atoms to which they are attached, forms
Rb2 is independently C1-4 alkyl or —C(O)OC1-4 alkyl; and
Rg2 is independently halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
with a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, R12 are as defined as above for Formula (II); and
R14 is independently H, halogen, or —OS(O)2Rb1; and Rb1 is as defined as above for Formula (IV);
and with a mixture of (a) a transition metal catalyst; with or without (b) a phosphine ligand; and (c) Base 2 selected from a Brønsted base and a Lewis base; in Solvent 3 that is a protic, aprotic or polar organic solvent media;
for a time and at a temperature sufficient for coupling and to produce a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 21 (depends on 20)

The method according to claim 20 for making a compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R3a is independently R3, C(O)Ra, —C(O)ORa,
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R8 is independently 5-membered heteroaryl wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
and
Re1 is independently H, C(O)Ra, —C(O)ORa,
comprising (1) contacting a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof:
wherein R4, R8, and R11 are as defined as above for Formula (II);
R13 is independently H, halogen, —OS(O)2Rb1, —B(OH)2, —B(OC1-4 alkyl)2, —BF3K,
Rb1 is independently C1-4 alkyl, C1-4 haloalkyl, or phenyl substituted with from 0 to 3 Rg2; and
Rg2 is independently halo, C1-4 alkyl, or C1-4 haloalkyl;
with a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, R12 are as defined as above for Formula (II); and
R14 is independently H, halogen, or —OS(O)2Rb1; and Rb1 is as defined as above for Formula (IV);
and with a mixture of (a) a transition metal catalyst; with or without (b) a phosphine ligand; and (c) Base 2 selected from a Brønsted base and a Lewis base; in Solvent 3 that is a protic, aprotic or polar organic solvent media;
for a time and at a temperature sufficient for coupling and to produce a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 22 (depends on 20, 21)

The method according to claim 20 or claim 21 for making a compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
comprising (1) contacting a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof, wherein R13 is independently H, halogen, —OMs, —OTs, —OTf, —B(OH)2, —BPin, —B(npg) or —BF3K;
with a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof wherein R14 is independently F, Cl, Br, —OMs, —OTs, or —OTf;
and with a mixture of (a) a transition metal catalyst selected from PdCl2(PPh3)2, Pd(AtaPhos)2Cl2, (DPEPhos)PdCl2, (DPPF)PdCl2, (PCy2tBu)2PdCl2, Pd(OAc)2, Pd2(dba)3, Pd(dba)2 (MeCN)2PdCl2, [(crotyl)PdCl]2, [(cinnamyl)PdCl]2 and [(allyl)PdCl]2; with or without (b) a phosphine ligand selected from PPh3, DPEPhos, DPPF, PCy2tBu, PCy2tBuHBF4, CyXantphos, PtBu2Me, PtBu2MeHBF4, XPhos and AtaPhos; and (c) Base 2 selected from K3PO4, KOH, K2CO3, NaOH, NaOMe, KOMe, NaOtBu, and KOtBu; in Solvent 3 selected from MeTHF, THF, MeOH, EtOH, dioxane, toluene, DMAc, DME and NMP or a combination thereof;
for a time from 1 to 96 hours and at a temperature ranging from 20° C. to 80° C. sufficient for coupling and to produce a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 23 (depends on 22)

The method according to claim 22 for making a compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
comprising (1) contacting a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof, with a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof, and with a mixture of (a) a transition metal catalyst selected from PdCl2(PPh3)2, Pd(AtaPhos)2Cl2, (DPEPhos)PdCl2, (DPPF)PdCl2, (PCy2tBu)2PdCl2, Pd(OAc)2, Pd2(dba)3, Pd(dba)2 (MeCN)2PdCl2, [(crotyl)PdCl]2, [(cinnamyl)PdCl]2 and [(allyl)PdCl]2; with or without (b) a phosphine ligand selected from PPh3, DPEPhos, DPPF, PCy2tBu, PCy2tBuHBF4, CyXantphos, PtBu2Me, PtBu2MeHBF4, XPhos and AtaPhos; and (c) Base 2 selected from aqueous K3PO4, aqueous KOH, aqueous K2CO3, aqueous NaOH, anhydrous NaOMe anhydrous KOMe, anhydrous NaOtBu, and anhydrous KOtBu; in Solvent 3 selected from MeTHF, THF, MeOH, EtOH, dioxane, toluene, DMAc, DME and NMP or a combination thereof;
for a time from 2 to 48 hours and at a temperature ranging from 20° C. to 80° C. sufficient for coupling and to produce a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 24 (depends on 23)

The method according to claim 23 for making a compound of Formula (II), or a tautomer, a stereoisomer or a salt thereof:
comprising (1) contacting a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof;
with a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof;
for a time from 4 to 20 hours and at a temperature ranging from 40° C. to 80° C. sufficient for coupling and to produce a compound of Formula (II), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 25

A compound of Formula (IV), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R8 is independently 5-membered heteroaryl wherein the heteroaryl includes 1 to 4 ring carbon atoms and 1 to 4 ring heteroatoms are each independently selected from: N, N(Re1), O, and S, and is substituted with from 0 to 3 Rg;
R11 is independently NH2 or NO2;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
Re1 is independently H, C(O)Ra, —C(O)ORa,
Rg1 is independently H, halo, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R13 is independently halogen, —OS(O)2Rb1, —B(ORb2)2, or —BF3K;
Rb1 is independently C1-4 alkyl, C1-4 haloalkyl, or phenyl substituted with from 0 to 3 Rg2;
Rb2 is independently H or C1-4 alkyl;
alternatively, two Rb2s together with the oxygen atoms to which they are attached, forms heterocyclyl including the boron atom and additional 2 to 5 ring carbon atoms, wherein the heterocyclyl is substituted with from 0 to 4 Rb2;
Rb2 is independently C1-4 alkyl or —C(O)OC1-4 alkyl;
alternatively, two Rb2s together with the oxygen atoms to which they are attached, forms
Rb2 is independently C1-4 alkyl or —C(O)OC1-4 alkyl; and
Rg2 is independently halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy.

### Claim 26 (depends on 25)

The compound according to claim 25, wherein:
R8 is independently N—(Re1)-pyrazolyl, N—(Re1)-thiazolyl;
R13 is halogen, —B(OH)2, —BPin or —BF3K;
Re1 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl,
and
Rg1 is independently H, halo or C1-4 alkyl.

### Claim 27 (depends on 25)

The compound according to claim 25, wherein:
R8 is N—(Re1)-pyrazolyl; and
Re1 is independently Bn, Boc, or

### Claim 28

A method of making a compound of Formula (IV), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R8 is independently N—(Re1)-pyrazolyl;
R11 is independently NH2 or NO2;
R13 is independently H, halogen, —OS(O)2Rb1, —B(OH)2, —BPin, —B(npg) or —BF3K;
Rb1 is independently C1-4 alkyl, C1-4 haloalkyl, or phenyl substituted with from 0 to 3 Rg2;
Re1 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl,
Rg1 is independently H, halo or C1-4 alkyl; and
Rg2 is independently halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
comprising (1) contacting a compound of Formula (VI) or a tautomer, a stereoisomer, or a salt thereof:
wherein R4, R11 and R13 are as defined as above for Formula (IV); and
R16 is independently halogen;
with a compound of Formula (VII) or a tautomer, a stereoisomer, or a salt thereof:
wherein: Re1 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl,
Rg1 is independently H, halo or C1-4 alkyl;
and with a mixture of (a) a transition metal catalyst; with or without (b) a phosphine ligand; (c) Base 3 selected from a Brønsted base and a Lewis base; and (d) a Zn salt; in Solvent 4 that is a
protic, aprotic, polar, non-polar organic solvent or organic solvent mixture;
for a time and at a temperature sufficient for coupling to produce a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 29 (depends on 28)

The method according to claim 28 for making a compound of Formula (IV), or a tautomer, a stereoisomer or a salt thereof; wherein:
R8 is independently N—(Re1)-pyrazolyl;
R13 is halogen, —B(OH)2, —BPin or —B(npg); and
Re1 is independently Bn or
comprising (1) contacting a compound of Formula (VI) or a tautomer, a stereoisomer, or a salt thereof; wherein R16 is independently Cl or Br;
with a compound of Formula (VII) or a tautomer, a stereoisomer, or a salt thereof, wherein: Re1 is independently Bn or
and with a mixture of (a) a transition metal catalyst selected from Pd(Xantphos)Cl2, Pd(DPEPhos)Cl2, Pd(Oac)2, and [(allyl)PdCl]2; with or without (b) a phosphine ligand selected from Xantphos, DPEPhos, Xphos, PtBu3HBF4, AtaPhos, RuPhos, Cy-JohnPhos, Cy-DavePhos, DPP-DtBPF, PPh3, P(fur)3, PPh2(o-anis),
P(p-CF3-Ph)3, P(o-Tol)3, Pcy3 HBF4, PPh2Pyr, PtBu2Me HBF4, AcaPhos, CX-Abn,
S-Phos, JackiePhos, tB-Xantphos, DPPE, DCPP, DPPB, DCPB HBF4, DPPPent, BISBI, DPPF, DcyPF, BiPHEP, and Cy-BIPHEP; © Base 3 selected from n-hexyllithium,
n-octyllithium and n-butyllithium; and (d) a Zn salt selected from ZnCl2, ZnBr2, Zn(Opiv)2, and Zn(Otf)2; in Solvent 4 selected from Toluene, isopropanol, MTBE, CPME, THF, 2-Me-THF, MeOH, EtOH, n-BuOH, t-amyl alcohol, acetone, MEK, MIBK, MeCN, DMSO, EtOAc, IPAc, anisole, DMF, DCM, DCE, NMP, heptane, hexane, cyclohexane, and water, or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from −78° C. to 80° C. sufficient for coupling to produce a compound of Formula (IV), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 30

A method of making a compound of Formula (IVa), or a tautomer, a stereoisomer or a salt thereof:
comprising (1) contacting a compound of Formula (VIb) or a tautomer, a stereoisomer, or a salt thereof:
wherein:
R4 is independently H, halogen, cyano, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
R8 is independently N—(Re1)-pyrazolyl;
R11 is independently NH2 or NO2;
R13a is independently —B(OH)2, —BPin, —B(npg) or —BF3K;
R13b is independently halogen;
Re1 is independently H, C(O)C1-4 alkyl, —C(O)OC1-4 alkyl,
and
Rg1 is independently H, halo or C1-4 alkyl;
and with a mixture of (a) a transition metal catalyst; with or without (b) a phosphine ligand; (c) Base 4 selected from a Brønsted base and a Lewis base; and (d) a borylation reagent; in Solvent 5 that is a protic, aprotic, polar, non-polar organic solvent or organic solvent mixture;
for a time and at a temperature sufficient for coupling to produce a compound of Formula (IVa), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 31 (depends on 30)

The method according to claim 30 for making a compound of Formula (Iva), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (Vib) or a tautomer, a stereoisomer, or a salt thereof, and with a mixture of (a) a transition metal catalyst selected from [(allyl)PdCl]2, [(cinnamyl)PdCl]2, [(crotyl)PdCl]2, PdCl2(MeCN)2, (Xphos) palladium(II) phenethylamine chloride, Xphos aminobiphenyl palladium chloride, Xphos aminobiphenyl palladium methanesulfonate, NiCl2-6H2O, Ni(NO3)2-6H2O, and Ni(cod)2; with or without (b) a phosphine ligand selected from Xphos, XPhosHBF4, P(DMM-Ph)3, CX-POMeCy, CX-A, DPEphos, Cy-JohnPhos, Cphos, CX-POMeCy, or CX-Pcy; (c) Base 4 selected from KOPiv, NaOPiv, NaOAc, KOAc, or DIPEA; and (d) a borylation reagent selected from B2(OH)4, B2(Pin)2 or B2(npg)2; in Solvent 5 selected from MeOH, EtOH, MeTHF, and THF or a combination thereof;
for a time from 1 to 72 hours and at a temperature ranging from −10° C. to 50° C. for coupling to produce a compound of Formula (Iva), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 32

A compound of Formula (VIII), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
R14 is independently H, halogen, or —OS(O)2Rb1;
R15 is independently CN, CF3, —C(O)NH2, —C(NH)NH2, —CH═NOH, —C(O)ORa, or —C(O)SRa;
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano;
Rg1 is independently H, halo or C1-4 alkyl.
Rb1 is independently C1-4 alkyl, C1-4 haloalkyl, or phenyl substituted with from 0 to 3 Rg2; and
Rg2 is independently halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy.

### Claim 33 (depends on 32)

The compound according to claim 32, wherein:
R14 is independently H, Cl, Br, I, —Oms, —Ots, or —Otf; and
R15 is independently CN, CF3, or —C(O)NH2.

### Claim 34 (depends on 33)

The compound according to claim 33, wherein:
R14 is independently H, Cl, Br, I, —Oms, —Ots, or —Otf; and
R15 is independently CN or CF3.

### Claim 35

A method of making a compound of Formula (V), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
R14 is halogen;
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano; and
Rg1 is independently H, halo or C1-4 alkyl;
comprising (1) contacting a compound of Formula (Va) or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3 and R12 are as defined as above for Formula (V);
with a mixture of (a) an electrophilic halogenation reagent; with or without (b) a Brønsted base; and with or without (c) a Brønsted acid; in Solvent 6 a protic, aprotic, polar organic solvent, and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 36 (depends on 35)

The method according to claim 35 for making a compound of Formula (V), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (Va) or a tautomer, a stereoisomer, or a salt thereof, with a mixture of (a) an electrophilic halogenation reagent selected from NCS, NBS, NIS, pyridinium hydrobromide perbromide, and I2/PhI(OAc)2 mixture; with or without (b) a Brønsted base selected from NaOAc, LiHMDS, DBU and pyridine; and with or without (c) AcOH; in Solvent 6 selected from MeOH, EtOH, IPA, MeCN, MTBE, DCM, EtOAc, water or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from 0° C. to 80° C. sufficient to produce a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 37 (depends on 36)

The method according to claim 36 for making a compound of Formula (V), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (Va) or a tautomer, a stereoisomer, or a salt thereof;
with a mixture of (a) an electrophilic halogenation reagent selected from NCS, NBS, NIS, pyridinium hydrobromide perbromide, and I2/PhI(OAc)2 mixture; with (b) a Brønsted base selected from NaOAc, LiHMDS, DBU and pyridine; and followed by (c) AcOH; in Solvent 6 selected from MeOH, EtOH, IPA, MeCN, MTBE, DCM, EtOAc, water or a combination thereof;
for a time from 1 to 48 hours and at a temperature ranging from 0° C. to 80° C. sufficient to produce a compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 38

A method of making a compound of Formula (Va), or a tautomer, a stereoisomer or a salt thereof:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
Ra is, at each occurrence, independently:
(i) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano; and
Rg1 is independently H, halo or C1-4 alkyl;
comprising (1) contacting a compound of Formula (XI) or a tautomer, a stereoisomer, or a salt thereof:
wherein R2 and R12 are as defined as above for Formula (Va);
with a mixture of (a) a starting material selected from 3,3-dibromo-1,1,1-trifluoropropan-2-one, 3,3-dibromo-1,1,1-trifluoropropan-2-one hydrate, 3,3-dichloro-1,1,1-trifluoropropan-2-one, 3,3-dichloro-1,1,1-trifluoropropan-2-one hydrate, trifluoropyruvaldehyde and 3,3,3-trifluoro-2,2-dihydroxy-propanal; (b) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with or without (c) AcOH or NH4OAc; and with or without (d) Base 5 selected from K3PO4, Na3PO4, LiOH, NaOH, KOH, and CsOH; in Solvent 7 selected from IPA, MeOH, EtOH, THF, MTBE, CPME, nBuOAc and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Va), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 39 (depends on 38)

The method according to claim 38 for making a compound of Formula (Va), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (XI) or a tautomer, a stereoisomer, or a salt thereof, with a mixture of (a) a starting material selected from 3,3-dibromo-1,1,1-trifluoropropan-2-one, 3,3-dibromo-1,1,1-trifluoropropan-2-one hydrate, 3,3-dichloro-1,1,1-trifluoropropan-2-one, 3,3-dichloro-1,1,1-trifluoropropan-2-one hydrate, trifluoropyruvaldehyde and 3,3,3-trifluoro-2,2-dihydroxy-propanal; (b) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with (c) AcOH or NH4OAc; and followed by (d) Base 5 selected from K3PO4, Na3PO4, LiOH, NaOH, KOH, and CsOH; in Solvent 7 selected from IPA, MeOH, EtOH, THF, MTBE, CPME, nBuOAc and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Va), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 40

A method of making a compound of Formula (V), or a tautomer, a stereoisomer or a salt thereof:
wherein:
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
R14 is halogen;
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano; and
Rg1 is independently H, halo or C1-4 alkyl;
comprising (1) contacting a compound of Formula (XI) or a tautomer, a stereoisomer, or a salt thereof:
wherein R2 and R12 are as defined as above for Formula (Va);
with a mixture of (a) glyoxal or glyoxal hydrate; (b) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with or without (c) AcOH or NH4Oac; in Solvent 8 selected from MeOH, EtOH, IPA, n-propanol, n-butanol, MTBE, CPME, nBuOAc, and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Vb), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, and R12 and other variables are as defined as above for Formula (Va);
and (2) contacting the compound of (Vb), or a tautomer, a stereoisomer, or a salt thereof;
with a mixture of (a) NIS or 12; with or without (b) NaOAc, NaHCO3, or KHCO3; in Solvent 8 selected from MeOH, EtOH, IPA, n-propanol, n-butanol, water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Vc), or a tautomer, a stereoisomer, or a salt thereof:
wherein R2, R3, and R12 and other variables are as defined as above for Formula (Va);
and (3) contacting the compound of (Vc), or a tautomer, a stereoisomer, or a salt thereof;
with a mixture of (a) an electrophilic cyanation reagent; (b) a Grignard reagent; in Solvent 10 that is an aprotic organic solvent or its organic solvent mixture;
for a time and at a temperature sufficient to produce the compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 41 (depends on 40)

The method according to claim 40 for making a compound of Formula (V), or a tautomer, a stereoisomer or a salt thereof;
comprising (1) contacting a compound of Formula (XI) or a tautomer, a stereoisomer, or a salt thereof, with a mixture of (a) glyoxal or glyoxal hydrate; (b) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with or without (c) AcOH or NH4OAc; in Solvent 7 selected from MeOH, EtOH, IPA, n-propanol, n-butanol, MTBE, CPME, nBuOAc, and water or a combination thereof;
for a time from 1 h to 96 hours and at a temperature ranging from 0° C. to 80° C. to produce a compound of Formula (Vb), or a tautomer, a stereoisomer, or a salt thereof;
and (2) contacting the compound of (Vb), or a tautomer, a stereoisomer, or a salt thereof;
with a mixture of (a) NIS or 12; with or without (b) NaOAc, NaHCO3, or KHCO3; in Solvent 8 selected from MeOH, EtOH, IPA, n-propanol, n-butanol, water or a combination thereof;
for a time from 5 min to 48 hours and at a temperature ranging from 0° C. to 80° C. sufficient to produce a compound of Formula (Vc), or a tautomer, a stereoisomer, or a salt thereof;
and (3) contacting the compound of (Vc), or a tautomer, a stereoisomer, or a salt thereof;
with a mixture of (a) an electrophilic cyanation reagent selected from 1H-imidazole-1-carbonitrile, 1H-Benzotriazole-1-carbonitrile, and phenyl cyanate; (b) a Grignard reagent selected from isopropylmagnesium chloride lithium chloride complex, sec-butylmagnesium chloride lithium chloride complex, isopropylmagnesium bromide, isopropylmagnesium chloride, ethylmagnesium bromide, and methylmagnesium bromide; in Solvent 10 selected from THF, 2-Me-THF, MTBE, CPME, and IPAc or a combination thereof;
for a time from 5 min to 48 hours and at a temperature ranging from −20° C. to 80° C. sufficient to produce the compound of Formula (V), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 42

A method of making a compound of Formula (Va), or a tautomer, a stereoisomer or a salt thereof;
R2 is independently H or C1-6 alkyl;
R3 is independently H, C1-6 haloalkyl, or C1-8 alkyl optionally substituted with R6, wherein R6 is OH, C1-4 alkoxy, C1-4 haloalkoxy, CO2Ra, or —CONRcRd;
R12 is independently H, triphenylmethyl, C(O)Ra, —C(O)ORa, —S(O)1-2(Rb), or
Ra is, at each occurrence, independently:
(vi) C1-6 alkyl optionally substituted with from 1 to 2 Rh;
(ii) C1-6 haloalkyl;
(iii) —(C0-3 alkylene)-C3-6 cycloalkyl, wherein the cycloalkyl is optionally substituted with from 1 to 2 Rf;
(iv) —(C0-3 alkylene)-heterocyclyl including from 3 to 8 ring atoms, wherein from 1 to 3 ring atoms are each independently selected from N(Re), O, and S, wherein the heterocyclyl is optionally substituted with from 1 to 4 independently selected Rf;
(v) —(C0-3 alkylene)-phenyl optionally substituted with from 1 to 4 independently selected Rg; or
(vi) —(C0-3 alkylene)-heteroaryl including from 5 to 6 ring atoms, wherein from 1 to 4 ring atoms are each independently selected from N, N(Re), O, and S, wherein the heteroaryl is optionally substituted with from 1 to 3 independently selected Rg;
Rb is C1-6 alkyl;
each occurrence of Rc and Rd is independently H or C1-4 alkyl;
each occurrence of Re is independently H or C1-4 alkyl;
each occurrence of Rf is independently C1-6 alkyl, C1-4 haloalkyl, OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, or phenyl optionally substituted with from 1 to 4 Rg;
each occurrence of Rg is independently halogen, cyano, C1-6 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
each occurrence of Rh is independently OH, F, Cl, C1-4 alkoxy, C1-4 haloalkoxy, or cyano; and
Rg1 is independently H, halo or C1-4 alkyl;
comprising (1) contacting a compound of Formula (XI) or a tautomer, a stereoisomer, or a salt thereof:
wherein R2 and R12 are as defined as above for Formula (Va);
with a mixture of (a) a starting material selected from 3,3-dibromo-1,1,1-trifluoropropan-2-one, 3,3-dibromo-1,1,1-trifluoropropan-2-one hydrate, 3,3-dichloro-1,1,1-trifluoropropan-2-one, 3,3-dichloro-1,1,1-trifluoropropan-2-one hydrate, trifluoropyruvaldehyde and 3,3,3-trifluoro-2,2-dihydroxy-propanal; (b) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with or without (c) AcOH or NH4Oac; and with or without (d) Base 5 selected from K3PO4, Na3PO4, LiOH, NaOH, KOH, and CsOH; in Solvent 7 selected from IPA, MeOH, EtOH, THF, MTBE, CPME, nBuOAc and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Vd), or a tautomer, a stereoisomer, or a salt thereof;
wherein R2, R3 and R12 are as defined as above for Formula (Va);
and (2) contacting a compound of Formula (Vd) or a tautomer, a stereoisomer, or a salt thereof, with a mixture of (a) aqueous ammonium hydroxide, ammonium chloride, ammonium bromide, ammonium fluoride, ammonium iodide, ammonium acetate, ammonium carbonate, ammonium dihydrogenphosphate, ammonium phosphate dibasic, ammonium formate, ammonium hydrogensulfate, and ammonium sulfate; with or without (b) Base 6 selected from K3PO4, Na3PO4, LiOH, NaOH, KOH, and CsOH; in Solvent 8 selected from IPA, MeOH, EtOH, THF, MTBE, CPME, nBuOAc and water or a combination thereof;
for a time and at a temperature sufficient to produce a compound of Formula (Va), or a tautomer, a stereoisomer, or a salt thereof.

### Claim 43

A method of preparing Compound 1, or a tautomer, or a salt thereof:
comprising 1) contacting a compound of Compound 2, or a tautomer, or a salt thereof, wherein:
with a mixture of an acylation reagent, with Base 7 selected from organic and inorganic bases, in Solvent 9 that is a protic, aprotic or polar organic solvent, water or the solvent mixture;
for a time and at a temperature sufficient for acylation and to produce Compound 1 and its over-acetylated derivatives;
followed by treating the reaction mixture with or without Base 8 selected from organic and inorganic bases in Solvent 9;
for a time at a temperature sufficient to convert its over-acetylated derivatives to Compound 1; and
2) the reaction mixture is treated with acetic acid to adjust pH to 7.0-12.5 to crystallize in sufficient yield and control crystal form produce Compound 1, or a tautomer, a stereoisomer, or a salt thereof.

### Claim 44 (depends on 43)

The method according to claim 43, comprising 1) and 2) in claim 43, further 3) drying Compound 1 at humidity, temperature, and pressure controlled conditions sufficient to remove residual solvent, water and maintain crystalline Form A without over dehydration.

### Claim 45 (depends on 43)

The method according to claim 43, comprising 1) contacting a compound of Compound 2, or a tautomer, or a salt thereof, with a mixture of an acylation reagent selected from acetic anhydride, acetyl chloride, 1-acetylimidazole, 2,2,2-trifluoroethyl acetate, 1-(trifluoromethyl)vinyl acetate, pentafluoro-2-propenyl acetate, and 1,1,1-trichloroacetone, with Base 7 selected from selected from N-Me-pyrrolidine, diisopropylethylamine, tert-butyl-tetramethylguanidine, 1,8-Diazabicyclo(5.4.0)undec-7-ene, 1,5-Diazabicyclo[4.3.0]non-5-ene, N-Me-piperidine, dimethylisopropylamine, dimethylpiperazine, 2-Me-pyridine, N-Me-imidazole, 2,6-lutidine, trimethylamine, 4-Me-morpholine, tetramethylguanidine, dimethylethylamine, tetramethylethylenediamine, aqueous NaOH, aqueous KOH, and aqueous LiOH, aqueous Bu4NOH, aqueous Et4NOH, aqueous Na2CO3, aqueous K2CO3, quinuclidine, tris(hydroxymethyl)aminomethane, and aqueous K2HPO4, in Solvent 9 selected from water, NMP, DMAc, DMF, THF, IPA, CH3CN, MeOH, EtOH, or the solvent mixture;
for a time 5 min to 8 h and at a temperature of 0 to 50° C. sufficient for acylation and to produce Compound 1 and its over-acetylated derivatives;
followed by treating the reaction mixture with or without Base 8 selected from ethylenediamine, N,N-dimethylethylenediamine, N,N′-dimethylethylenediamine, ethanolamine, n-butylamine, 1,3-diamino propane, isopropylamine, 2-hydroxymethylpiperidine, benzylmethylamine, 3-dimethylamino-1-propylamine, N-Methyl piperidine, cyclohexylamine, diethanolamine, diethylamine, hexamethyleneimine, morpholine, N-ethyl ethanolamine, piperazine, thiamorpholine, tert-butyl-tetramethylguanidine, 1-(3-aminopropyl)hexahydro-2H-azepin-2-one, aqueous NaOH, aqueous KOH, aqueous LiOH, aqueous NH4OH, aqueous Bu4NOH, and aqueous Et4NOH, in Solvent 9;
for a time of 30 min to 48 h at a temperature of 10 to 70° C. sufficient to convert its over-acetylated derivatives to Compound 1; and
2) the reaction mixture is treated with acetic acid to adjust pH to 7.0-12.5 to crystallize in sufficient yield and control crystal form produce Compound 1, or a tautomer, a stereoisomer, or a salt thereof.

### Claim 46 (depends on 45)

The method according to claim 45, comprising 1) and 2) in claim 45, further 3) drying Compound 1 at a humidity of 5% RH to 100% RH, temperature of 10 to 60° C., and pressure of 100 mbar to atmosphere pressure, sufficient to remove residual solvent, water and maintain crystalline Form A without over dehydration.

### Claim 47

A compound having the following formula:

### Claim 48

A compound having the following formula:
